The Secret Drug Pricing System Middlemen Use to Rake in Millions

The Secret Drug Pricing System Middlemen Use to Rake in Millions

Posted by on Sep 20, 2018 in News |

By Robert Langreth Bloomberg: Not everybody reads the legal notices inside the Ottumwa Courier. But in January, Iowa pharmacist Mark Frahm noticed something unusual in the paper. For years, Frahm’s South Side Drug bought pills from distributors, and dispensed prescriptions to the Wapello County jail. In turn, the pharmacy got reimbursed for the drugs by...

Read More

Feeling the pain of rising drug prices? Blame the middle man

Feeling the pain of rising drug prices? Blame the middle man

Posted by on Sep 20, 2018 in News |

Wink News: While Washington wrangles with a replacement for Obamacare, patients across the country continue to battle one of the biggest everyday obstacles to good health care: Rising drug prices. Prescription drugs account for 10 percent of the $3.2 trillion in overall health care spending, outpacing all other health care services, according to government...

Read More

Why a patient paid a $285 copay for a $40 drug

Why a patient paid a $285 copay for a $40 drug

Posted by on Sep 20, 2018 in News |

By Megan Thompson PBS: Two years ago Gretchen Liu, 78, had a transient ischemic attack — which experts sometimes call a “mini stroke” — while on a trip to China. After she recovered and returned home to San Francisco, her doctor prescribed a generic medication called telmisartan to help manage her blood pressure. Liu and her husband Z. Ming Ma, a retired...

Read More

Do prescription drug middlemen help keep prices high?

Do prescription drug middlemen help keep prices high?

Posted by on Sep 20, 2018 in News |

By Megan Thompson & Mori Rothman PBS: Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for a portion of those high costs through their role as middlemen between insurance plans, drug makers and pharmacies—but...

Read More